Combination of tumor markers predicts progression and pathological response in patients with locally advanced gastric cancer after neoadjuvant chemotherapy treatment

BACKGROUND: The prognostic values of preoperative tumor markers (TMs) remain elusive in patients with locally advanced gastric cancer (LAGC) after neoadjuvant chemotherapy treatment (NACT). This study aimed to assess and establish a novel scoring system incorporating carcinoembryonic antigen (CEA),...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Gastroenterol
Autors principals: Liu, Zining, Wang, Yinkui, Shan, Fei, Ying, Xiangji, Zhang, Yan, Li, Shuangxi, Jia, Yongning, Miao, Rulin, Xue, Kan, Li, Zhemin, Li, Ziyu, Ji, Jiafu
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2021
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8272383/
https://ncbi.nlm.nih.gov/pubmed/34246249
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12876-021-01785-7
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars